These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 18541891)

  • 1. Re: LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Bonifati V; Wu-Chou YH; Schweiger D; Fonzo AD; Lu CS; Oostra B
    Neurology; 2008 Jun; 70(24):2348; author reply 2348-9. PubMed ID: 18541891
    [No Abstract]   [Full Text] [Related]  

  • 2. LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.
    Nichols WC; Elsaesser VE; Pankratz N; Pauciulo MW; Marek DK; Halter CA; Rudolph A; Shults CW; Foroud T;
    Neurology; 2007 Oct; 69(18):1737-44. PubMed ID: 17804834
    [TBL] [Abstract][Full Text] [Related]  

  • 3. LRRK2: both a cause and a risk factor for Parkinson disease?
    Foroud T
    Neurology; 2005 Sep; 65(5):664-5. PubMed ID: 16157895
    [No Abstract]   [Full Text] [Related]  

  • 4. A common leucine-rich repeat kinase 2 gene mutation in familial and sporadic Parkinson's disease in Russia.
    Illarioshkin SN; Shadrina MI; Slominsky PA; Bespalova EV; Zagorovskaya TB; Bagyeva GKh; Markova ED; Limborska SA; Ivanova-Smolenskaya IA
    Eur J Neurol; 2007 Apr; 14(4):413-7. PubMed ID: 17388990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lrrk2 in the limelight!
    Farrer MJ
    Neurology; 2007 Oct; 69(18):1732-3. PubMed ID: 17967990
    [No Abstract]   [Full Text] [Related]  

  • 6. [A PARK8 form of Parkinson's disease: a mutational analysis of the LRRK2 gene in Russian population].
    Shadrina MI; Illarioshkin SN; Bagyeva GKh; Bespalova EV; Zagorodskaia TB; Slominskiĭ PA; Markova ED; Kliushnikov SA; Limborskaia SA; Ivanova-Smolenskaia IA
    Zh Nevrol Psikhiatr Im S S Korsakova; 2007; 107(3):46-50. PubMed ID: 18379513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. LRRK2 R1441G in Spanish patients with Parkinson's disease.
    Mata IF; Taylor JP; Kachergus J; Hulihan M; Huerta C; Lahoz C; Blazquez M; Guisasola LM; Salvador C; Ribacoba R; Martinez C; Farrer M; Alvarez V
    Neurosci Lett; 2005 Jul; 382(3):309-11. PubMed ID: 15925109
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical features of Parkinson disease patients with homozygous leucine-rich repeat kinase 2 G2019S mutations.
    Ishihara L; Warren L; Gibson R; Amouri R; Lesage S; Dürr A; Tazir M; Wszolek ZK; Uitti RJ; Nichols WC; Griffith A; Hattori N; Leppert D; Watts R; Zabetian CP; Foroud TM; Farrer MJ; Brice A; Middleton L; Hentati F
    Arch Neurol; 2006 Sep; 63(9):1250-4. PubMed ID: 16966502
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanistic insight into the dominant mode of the Parkinson's disease-associated G2019S LRRK2 mutation.
    Luzón-Toro B; Rubio de la Torre E; Delgado A; Pérez-Tur J; Hilfiker S
    Hum Mol Genet; 2007 Sep; 16(17):2031-9. PubMed ID: 17584768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. LRRK2 gene in Parkinson disease: mutation analysis and case control association study.
    Paisán-Ruíz C; Lang AE; Kawarai T; Sato C; Salehi-Rad S; Fisman GK; Al-Khairallah T; St George-Hyslop P; Singleton A; Rogaeva E
    Neurology; 2005 Sep; 65(5):696-700. PubMed ID: 16157901
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A clinic-based study of the LRRK2 gene in Parkinson disease yields new mutations.
    Zabetian CP; Samii A; Mosley AD; Roberts JW; Leis BC; Yearout D; Raskind WH; Griffith A
    Neurology; 2005 Sep; 65(5):741-4. PubMed ID: 16157909
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical and positron emission tomography of Parkinson's disease caused by LRRK2.
    Hernandez DG; Paisán-Ruíz C; McInerney-Leo A; Jain S; Meyer-Lindenberg A; Evans EW; Berman KF; Johnson J; Auburger G; Schäffer AA; Lopez GJ; Nussbaum RL; Singleton AB
    Ann Neurol; 2005 Mar; 57(3):453-6. PubMed ID: 15732108
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The LRRK2 gene in Parkinson's disease: mutation screening in patients from Germany.
    Schlitter AM; Woitalla D; Mueller T; Epplen JT; Dekomien G
    J Neurol Neurosurg Psychiatry; 2006 Jul; 77(7):891-2. PubMed ID: 16788020
    [No Abstract]   [Full Text] [Related]  

  • 14. Low disease risk in relatives of north african lrrk2 Parkinson disease patients.
    Troiano AR; Elbaz A; Lohmann E; Belarbi S; Vidailhet M; Bonnet AM; Lesage S; Pollak P; Cazeneuve C; Borg M; Feingold J; Dürr A; Tazir M; Brice A;
    Neurology; 2010 Sep; 75(12):1118-9. PubMed ID: 20855856
    [No Abstract]   [Full Text] [Related]  

  • 15. [Pathogenesis of Parkinson's disease through LRRK2 mutation].
    Ohta E; Obata F
    Seikagaku; 2014 Feb; 86(1):92-7. PubMed ID: 24693706
    [No Abstract]   [Full Text] [Related]  

  • 16. [Mutation in LRRK2 is associated with familial presentation of Parkinson's disease in a Chilean kindred].
    Miranda M
    Rev Med Chil; 2007 Mar; 135(3):406-7. PubMed ID: 17505590
    [No Abstract]   [Full Text] [Related]  

  • 17. Frequency of LRRK2 mutations in early- and late-onset Parkinson disease.
    Clark LN; Wang Y; Karlins E; Saito L; Mejia-Santana H; Harris J; Louis ED; Cote LJ; Andrews H; Fahn S; Waters C; Ford B; Frucht S; Ottman R; Marder K
    Neurology; 2006 Nov; 67(10):1786-91. PubMed ID: 17050822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Escaping Parkinson's disease: a neurologically healthy octogenarian with the LRRK2 G2019S mutation.
    Kay DM; Kramer P; Higgins D; Zabetian CP; Payami H
    Mov Disord; 2005 Aug; 20(8):1077-8. PubMed ID: 16001413
    [No Abstract]   [Full Text] [Related]  

  • 19. Lrrk2 mutations in South America: A study of Chilean Parkinson's disease.
    Perez-Pastene C; Cobb SA; Díaz-Grez F; Hulihan MM; Miranda M; Venegas P; Godoy OT; Kachergus JM; Ross OA; Layson L; Farrer MJ; Segura-Aguilar J
    Neurosci Lett; 2007 Jul; 422(3):193-7. PubMed ID: 17614198
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genomewide linkage study of modifiers of LRRK2-related Parkinson's disease.
    Latourelle JC; Hendricks AE; Pankratz N; Wilk JB; Halter C; Nichols WC; Gusella JF; Destefano AL; Myers RH; Foroud T;
    Mov Disord; 2011 Sep; 26(11):2039-44. PubMed ID: 21661047
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.